 |
|
Quality of Life in Patients With Atrial Fibrillation
Berndt Lüderitz, MD;
Werner Jung, MD
Arch Intern Med. 2000;160:1749-1757.
Atrial fibrillation (AF) is a frequent and costly health care problem. In patients with AF, the restoration and maintenance of sinus rhythm is the primary therapeutic goal. The most frequent strategy for maintaining sinus rhythm after restoration is the use of antiarrhythmic drugs. The efficacy of therapy in AF has been predominantly measured using objective criteria such as mortality and morbidity. In recent years, the importance of quality of life (QoL) as an outcome measure has been recognized. However, few studies in the literature have examined QoL in patients with AF using properly validated tools. In addition, the specific impact of antiarrhythmic drug treatment on QoL in patients with AF has not been assessed. These issues are now being addressed in several ongoing studies. This article attempts to define QoL, makes recommendations on how QoL might be assessed, reviews our current knowledge regarding QoL in patients with AF, and discusses new clinical trials currently assessing QoL in patients with AF.
From the Department of Medicine-Cardiology, University of Bonn, Bonn, Germany.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Catheter Ablation for Atrial Fibrillation in Patients With Obesity
Cha et al.
Circulation 2008;117:2583-2590.
ABSTRACT
| FULL TEXT
The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm
Van Gelder and Hemels
Europace 2006;8:943-949.
ABSTRACT
| FULL TEXT
Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation: A Veterans Affairs Cooperative Studies Program Substudy
Singh et al.
J Am Coll Cardiol 2006;48:721-730.
ABSTRACT
| FULL TEXT
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
Lloyd-Jones et al.
Circulation 2004;110:1042-1046.
ABSTRACT
| FULL TEXT
Quality of life in nonpharmacologic treatment of atrial fibrillation
Engelmann and Pehrson
Eur Heart J 2003;24:1387-1400.
ABSTRACT
| FULL TEXT
Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study
Pappone et al.
J Am Coll Cardiol 2003;42:185-197.
ABSTRACT
| FULL TEXT
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study
Carlsson et al.
J Am Coll Cardiol 2003;41:1690-1696.
ABSTRACT
| FULL TEXT
Quality of life in atrial fibrillation: relevance of the autonomic nervous system
Lewalter and Luderitz
Eur Heart J 2001;22:196-197.
|
